Clinical trial

Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer

NCT00923637

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2009-06-01

PhasePHASE2

Study timeline

Study start (unknown)2009-06-01Date precision: month

Registry last updated2009-06-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

Pemetrexed/OxaliplatinDRUG

Sponsors & collaborators

The First Affiliated Hospital of Guangzhou Medical Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00923637 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.